A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

Clinical trial NCT05333289 · COMPLETED

Trial details

NCT number: NCT05333289
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2022-04-06
Primary completion: 2022-11-22
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.